Tag: analgesics market size

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Analgesics Market Expected To Expand Between 2025 And 2029?

The analgesics market has shown consistent expansion in recent years. Its size is anticipated to increase from $110.47 billion in 2024 to $113.1 billion in 2025, achieving a compound annual growth rate (CAGR) of 2.4%. Historically, this growth can be ascribed to the influence of alternative therapies, findings from safety and efficacy studies, the widespread prevalence of pain, effective marketing and promotional efforts, and various economic aspects.

The analgesics market is anticipated to experience consistent expansion over the upcoming years. Its valuation is projected to reach $127.81 billion by 2029, achieving a compound annual growth rate (CAGR) of 3.1%. This projected growth during the forecast period stems from factors such as evolving pain management alternatives, increasing market competition, enhanced consumer health awareness, ongoing demographic shifts, and the escalating prevalence of chronic diseases. Key developments anticipated within this period encompass personalized medicine, the rise of non-opioid alternatives, the integration of CBD and cannabinoids, a focus on targeted pain management strategies, and improved accessibility and affordability.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

What Are The Top Growth Drivers Impacting The Analgesics Market Outlook?

The analgesics Market is being driven by a significant increase in chronic diseases. These drugs, also known as painkillers, are utilized to manage and lessen chronic or severe bodily pain caused by various medical issues. For instance, in September 2022, a report from the Switzerland-based health organization WHO highlighted that chronic diseases, sometimes referred to as noncommunicable diseases (NCDs), are long-term conditions stemming from a combination of genetic, physiological, environmental, and behavioral factors. NCDs are responsible for 41 million annual fatalities, which is 74% of all worldwide deaths. Annually, 17 million individuals die from an NCD before turning 70. A substantial 86% of these premature deaths occur in low- and middle-income nations, where 77% of all NCD-related deaths are observed. Thus, the growing prevalence of chronic illness is propelling the analgesics market.

What Are The Primary Types Of Segments Analyzed In The Analgesics Market?

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

Which Key Trends Are Expected To Influence The Analgesics Market In The Coming Years?

Businesses within the analgesics market are increasingly embracing investment as a primary strategy for achieving growth. Major manufacturers of analgesic drugs are channeling funds into clinical-stage companies to gain a competitive edge and solidify their market position. These investments contribute to companies’ ability to expand geographically and acquire specialized knowledge in the research and development of novel products. For instance, in January 2022, Concentric Analgesics, Inc., a US-based clinical-stage biopharmaceutical firm, announced the successful completion of a $20 million convertible note financing, secured from a mix of new and existing investors. This financing is intended to initiate registration-enabling Phase 3 studies for Vocacapsaicin, the company’s lead product candidate, which is already prepared for Phase 3. The funds will also be used to further support Phase 3 development activities for Vocacapsaicin, Concentric Analgesics’ primary therapeutic candidate for addressing post-surgical pain. The completion of this financing represents a critical development for Concentric Analgesics, as it enables the company to continue advancing Vocacapsaicin into Phase 3 development and serves as an important initial step toward fully funding the program through its NDA submission.

Who Are The Primary Competitors In The Global Analgesics Market?

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

How Does The Analgesics Market Perform Across Key Geographic Regions?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Analgesics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

Browse Through More Reports Similar to the Global Analgesics Market 2025, By The Business Research Company

Anti Infective Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Dermatology Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Analgesics Sector?

The size of the analgesics market has been on a consistent upward trajectory in the past few years. The market is anticipated to expand from $110.47 billion in 2024 to $113.1 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 2.4%. The growth during the historical period can be linked to the influence of alternative therapies, findings from safety and efficacy studies, the prevalence of pain, marketing strategies, and economic conditions.

The market for analgesics is forecasted to experience consistent expansion in the upcoming years. Its value is estimated to reach “$127.81 billion in 2029, growing at a compound annual growth rate (CAGR) of 3.1%. Factors contributing to this expected growth in the forecast period include alternatives for pain management, competitive market factors, increased awareness of consumer health, demographic changes, and a rise in chronic diseases. Key trends expected during this period encompass personalized healthcare, non-opioid substitutes, the use of CBD and other cannabinoids, targeted pain management techniques, and improved access and affordability.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

What Forces Are Driving The Growth Of The Analgesics Market?

The increased incidence of chronic diseases is propelling the growth of the analgesics market. Painkillers, alternatively known as analgesic drugs, are employed to alleviate severe or chronic body pain stemming from various health issues. To illustrate, the World Health Organization, a Swiss health entity, reported in September 2022 that chronic diseases, often referred to as noncommunicable diseases (NCDs), evolve over a prolonged time due to a mix of genetic, physiological, behavioral, and environmental factors. NCDs are responsible for 41 million deaths annually, constituting 74% of global mortalities. Each year, 17 million people under 70 succumb to an NCD, and these premature fatalities account for 86% of deaths in less wealthy countries. Interestingly, 77% of NCD-related deaths transpire in low- and middle-income nations. Thus, the escalating incidence of chronic ailments is a major factor propelling the expansion of the analgesics market.

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

Which Emerging Trends And Strategic Shifts Are Shaping The Analgesics Market?

The analgesics marketplace is witnessing a surge of investments aimed at promoting growth, with top-ranked analgesic pharmaceutical producers infusing capital into clinical-stage firms. Through this, they not only manage to secure a competitive footing but also reinforce their market dominance. One of the major benefits of these investments is that they enable businesses to broaden their global footprint and shed light on novel products’ research and development. A case in point is Concentric Analgesics, Inc., a clinical-stage biopharmaceutical corporation in the US, which confirmed the closure of a $20 million convertible note financing deal involving a mix of new and previous investors in January 2022. With the intention of kick-starting registration-enabling phase 3 investigations for Vocacapsaicin, the capital infusion would also be utilized to accelerate Phase 3 development activities for Vocacapsaicin, post-surgical pain lead therapeutic candidate of Concentric Analgesics. This financial closure holds immense significance for Concentric Analgesics by enabling the firm’s continuous stride towards pushing Vocacapsaicin into Phase 3 development, thereby marking a pivotal initial move towards underwriting the program in its entirety until the NDA submission.

Which Companies Currently Dominate The Competitive Landscape In The Analgesics Industry?

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Geographic Regions Are Driving Demand In The Analgesics Market?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Analgesics Market Evolve in Terms of Growth and Size by 2029?

The steady expansion of the analgesics market size has been observed in the past few years. It is projected to rise from $110.47 billion in 2024 to $113.1 billion in 2025, with a compound annual growth rate (CAGR) of 2.4%. The growth experienced in the historical period can be traced back to factors like the influence of alternate therapies, safety and efficacy research, prevalence of pain, marketing strategies, and economic factors.

It is anticipated that the analgesics market will sustain a consistent growth in the forthcoming years, reaching a valuation of $127.81 billion by 2029 with a compound annual growth rate (CAGR) of 3.1%. This expansion during the projected period can be ascribed to factors like alternate pain management options, market rivalry, increasing consumer health consciousness, demographic changes, and escalating chronic illnesses. The forecast period will be characterized by key trends such as personalised medication, non-opioid alternatives, the application of CBD and cannabinoids, sophisticated pain management, as well as improving accessibility and affordability.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

What factors are expected to fuel Analgesics market growth in the coming years?

The increase in the occurrence of chronic illnesses is propelling the analgesics market. Medicines for pain relief, also recognized as analgesics, are utilized to alleviate intense or chronic pain caused by a variety of health conditions. For instance, a report by the World Health Organization (WHO), based in Switzerland, in September 2022 indicates that chronic diseases, often known as noncommunicable diseases (NCDs), manifest over long durations due to the interaction of genetic, physiological, environmental and behavioral factors. NCDs contribute to 41 million deaths annually, representing 74% of global fatalities. Every year, 17 million people under the age of 70 die from NCDs. These premature deaths make up 86% of the total in low and middle-income countries while NCD-related deaths constitute 77% of the total in these nations. As a result, the escalating prevalence of chronic disease is fueling the expansion of the analgesics market.

What Are The Key Findings From The Segmentation Analysis Of The Analgesics Market?

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

Which Trends Are Expected To Shape The Future Of The Analgesics Market?

Significant players in the wound care biologics area are prioritizing the creation of innovative materials such as bioengineered, electrospun synthetic polymer matrix. The goal is to improve healing rates for wounds and encourage tissue redevelopment. Such synthetic polymer matrices, when used in wound care biologics, speed up the healing process and bolster tissue growth. They do this by acting as a structure that promotes cell movement and proliferation. As an example, Royal Biologics, a leader in the orthobiologics and life science field in the US, unveiled two ground-breaking products in October 2024. These were featured at the symposium on advanced wound care and included peak powder collagen matrix and electrofiber 3D. The former aids healing in multiple types of wounds by forming a gel barrier that supports tissue growth, while the latter encourages cell movement and shortens recovery times. These developments have made a profound influence on the wound care biologics market by satisfying the increased need for effective healing methods.

What Are The Most Active Companies In The Analgesics Market Today?

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Regional Markets Are Attracting The Most Investment In Analgesics?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Analgesics Market?

In recent times, the size of the analgesics market has consistently expanded. Projected growth indicates an increase from $109.97 billion in 2024 to $113.96 billion in 2025, which signifies a compound annual growth rate (CAGR) of 3.6%. Several factors influenced the growth during the historic phase, including the impact of alternative therapies, safety and efficacy trials, the incidence of pain, marketing strategies, and economic factors.

What Growth Rate Is Forecasted for the Analgesics Market by 2029?

In the coming years, the analgesics market is projected to experience a stable expansion, with a size projected to reach $129.46 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 3.2%. The anticipated growth during this forecast period can be ascribed to various factors such as alternative pain management solutions, market rivalry, increased consciousness about health among consumers, demographic changes, and the rise of chronic ailments. Key trends to watch out for during the forecast period encompass personalized medicine, non-opioid alternatives, the usage of CBD and cannabinoids, specific pain management strategies, and the improvement in accessibility and affordability.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

Which Key Companies Are Shaping the Future of the Analgesics Market?

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

Which Factors Are Driving Demand in the Analgesics Industry?

The analgesics market is experiencing a significant boost due to the increased occurrence of chronic illnesses. Painkillers, also known as analgesics, are employed to alleviate severe or long-lasting pain caused by a variety of medical conditions. For instance, a report released by the Switzerland-based World Health Organization in September 2022 highlighted that chronic or noncommunicable diseases (NCDs) are diseases that evolve over a prolonged period due to a mix of genetic, physiological, environmental, and behavioral factors. NCDs are responsible for 41 million deaths each year, representing 74% of all global fatalities. Notably, 17 million people die prematurely from an NCD every year before reaching the age of 70. About 86% of these premature deaths occur in lower and middle-income countries, with 77% of deaths linked to NCDs taking place in these nations too. Hence, the increased occurrence of chronic illnesses is significantly contributing to the expansion of the analgesics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

How Is the Analgesics Market Segmented by Several Divisions?

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

What are the Emerging Market Trends Driving the Growth of the Analgesics Industry?

There is a growing trend among businesses in the analgesics sector to leverage investment as a growth strategy. Top manufacturers of pain-relief drugs are investing capital into clinical-stage firms to enhance their competitive edge and consolidate their position in the market. Such investments enable these companies to broaden their geographical reach and acquire specialized knowledge in the creation and growth of new products. A case in point occurred in January 2022 when Concentric Analgesics, Inc., a US-based clinical-stage biopharma firm, closed a $20 million convertible note financing deal with a mix of new and existing investors. The funding will kick-start Phase 3 trials for Vocacapsaicin, the firm’s lead product that’s ready for Phase 3. Additional financing will go towards Phase 3 development activities for the said medication, Concentric Analgesics’ primary therapeutic contender for post-operative pain management. This critical financing completion is a major milestone for Concentric Analgesics as it facilitates the forward movement of Vocacapsaicin into Phase 3 development. It’s also a crucial initial step towards completely financing the programme up to NDA submission.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Regions Are Driving Growth in the Analgesics Market?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2438

This Report Delivers Insight On:

1. How big is the analgesics market, and how is it changing globally?

2. Who are the major companies in the analgesics market, and how are they performing?

3. What are the key opportunities and risks in the analgesics market right now?

4. Which products or customer segments are growing the most in the analgesics market?

5. What factors are helping or slowing down the growth of the analgesics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theAnalgesics Market?

The increase in the incidence of chronic ailments is fueling the growth of the analgesics Market. Painkiller medications, also regarded as analgesics, are employed to lessen severe or ongoing bodily pain caused by various health problems. As an example, a report from the Switzerland-based health organization, WHO, in September 2022 highlighted that chronic diseases, often referred to as non-communicable diseases (NCDs), are health conditions that manifest over the long term due to a mix of genetic, physiological, environmental, and behavioural factors. Non-communicable diseases (NCDs) contribute to 41 million deaths annually, making up 74% of all fatalities globally. Each year, 17 million individuals succumb to an NCD before reaching the age of 70, accounting for 86% of the deaths in low-and middle-income countries. It’s noteworthy that 77% of NCD related fatalities happen in lower and middle-income nations. As such, the noticeable escalation in the occurrence of chronic diseases is steering the expansion of the analgesics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

#What Long-Term Growth Rate is Expected for theAnalgesics Market Between 2025 and 2034?

In recent times, the size of the analgesics market has been expanding consistently. The market is expected to jump from $109.97 billion in 2024 to $113.96 billion in 2025, showcasing a compound annual growth rate (CAGR) of 3.6%. Factors such as the impact of alternative therapies, effects of safety and efficacy studies, prevalence of pain, robust marketing and promotional strategies, as well as economic factors have contributed significantly to the growth experienced during the historic period.

The size of the analgesics market is projected to witness consistent growth in the forthcoming years, expanding to $129.46 billion by 2029 with a compound annual growth rate (CAGR) of 3.2%. The anticipated growth during this forecast period can be ascribed to several factors such as the emergence of alternative pain management solutions, competitive market scenarios, enhanced health awareness among consumers, demographic changes, and the increasing incidence of chronic diseases. The forecast period is also expected to be characterized by major trends like personalized medication, non-opioid substitutes, the use of CBD and cannabinoids, targeted pain management strategies, and improvements in accessibility and affordability.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2438

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theAnalgesics Market?

The analgesics market is witnessing a growing emphasis on investment as a mechanism for expansion by its key players. Top companies in the production of pain relief drugs are investing in businesses in the clinical stage in order to reinforce their competitive edge and solidify their market presence. These investments offer the companies the opportunity to grow geographically and acquire highly specialized knowledge in research and development of new products. As a recent example, Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company in the US, reported the closure of a $20 million convertible note financing in January 2022, brought about by a mix of new and former investors. This capital will be dedicated to launching registration-triggering Phase 3 trials for Vocacapsaicin, the company’s main product candidate ready for Phase 3. Furthermore, this financial backing will support Phase 3 development activities for Vocacapsaicin, the principal therapeutic candidate of Concentric Analgesics for postoperative pain. The completion of this financing round holds significant importance for Concentric Analgesics, as it facilitates the continuation of Vocacapsaicin progression into Phase 3 development, acting as a crucial initial phase for the complete funding of the program up to NDA submission.

Who Are the Key Market Players Influencing the Growth of the Corn and Analgesics Industry?

Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Key Market Segments Comprise the Analgesics Market and Drive Its Revenue Growth?

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=2438&type=smp

Which Regions Are Emerging as Leaders in the Analgesics Market?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Analgesics Market 2025, By The Business Research Company:

Aerial Imaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/aerial-imaging-global-market-report

Precision Guided Munition Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/precision-guided-munition-global-market-report

Light Weapons Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/light-weapons-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Significant is the Anticipated Growth Rate of the Analgesics Market from 2025 to 2034?

The size of the analgesics market has experienced consistent growth in recent years. The market is expected to expand from its $109.97 billion valuation in 2024 to reach $113.96 billion in 2025, displaying a compound annual growth rate (CAGR) of 3.6%. Factors contributing to its growth during the historic period include the influence of alternative therapies, safety and efficacy studies, pain prevalence, marketing and promotional activities, and economic factors.

In the coming years, the market size of analgesics is anticipated to experience consistent expansion. The forecast predicts growth to a market value of $129.46 billion by 2029, following a compound annual growth rate (CAGR) of 3.2%. This expected upward trajectory is largely due to factors such as alternatives for pain management, competitive market conditions, increased consumer awareness of health, demographic changes, and a rise in chronic illnesses. The forecast period will also see key trends like the incorporation of personalized medicine, the use of non-opioid options, CBD and cannabinoids, targeted pain management strategies, as well as improved accessibility and affordability.

What External and Internal Drivers Are Contributing to the Growth of the analgesics Market’s Growth?

The increase in occurrence of chronic diseases is contributing to the growth of the analgesics Market. Analgesic medicines, also referred to as painkillers, are utilized for treating and decreasing long-term or intense pain in the body due to numerous health conditions. For example, a report by WHO, a Switzerland-health organization, in September 2022 stated that chronic diseases or Noncommunicable diseases (NCDs) develop over a long period due to a mix of genetic, physical, environmental, and behavioral factors. These NCDs cause 41 million deaths each year, constituting 74% of global fatalities. 17 million people die annually from an NCD before reaching 70 years, with these premature deaths making up 86% of deaths in low-and middle-income countries. 77% of NCD-related deaths take place in low- and middle-income countries. Hence, the sharp increase in the prevalence of chronic diseases is propelling the expansion of the analgesics market.

Get Your Free Sample of the Global Analgesics Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2438&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Analgesics Market?

Major companies operating in the analgesics market include:

• Pfizer Inc._x000D_

• Johnson & Johnson Services Inc._x000D_

• Medley Pharmaceuticals Limited_x000D_

• AbbVie Inc._x000D_

• Bayer HealthCare Pharmaceuticals LLC_x000D_

How Are Market Trends Revolutionizing the Analgesics Industry in Recent Times?

The trend of investing in growth strategies is increasingly prevalent among companies in the analgesics market. Top manufacturers of analgesic drugs are pouring money into firms in the clinical stage to obtain an edge over their competitors and solidify their stance in the market. Such investments are enabling these companies to broaden their geographical reach and increase their specialized knowledge in product research and development. For instance, in January 2022, Concentric Analgesics, Inc., an American clinical-stage biopharmaceutical firm, unveiled that it successfully raised $20 million through convertible note financing from a mix of both new and existing investors. This funding will be utilised to kickstart Phase 3 studies for Vocacapsaicin, the company’s leading product candidate that’s ready for Phase 3. This capital will further support the Phase 3 development activities for Vocacapsaicin, Concentric Analgesics’ primary treatment candidate for post-operative pain. The successful completion of this funding marks a significant milestone for Concentric Analgesics, as it allows for the continuous progression of Vocacapsaicin into Phase 3 development and marks a crucial initial step toward completely financing the program through the NDA submission stage.

Get Instant Access to the Global Analgesics Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Analgesics Market?

The analgesics market covered in this report is segmented –

1) By Type: Non-opioids, Opioids

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores

3) By Application: Internal Analgesics, External Analgesics

Subsegments:

1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates

2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

Which Geographic Areas Are Influencing the Growth of the Analgesics Market?

North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period. The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Analgesics Market and Its Key Components?

Analgesics are the pain killers that are used to treat mild or severe pain, including musculoskeletal pain, surgical, trauma pain, cancer pain, or another type of pain. Examples of analgesics include codeine, hydrocodone, oxycodone, and methadone.

Browse Through More Similar Reports By The Business Research Company:

COVID-19 Detection Test Kits and Consumables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/covid-19-detection-test-kits-and-consumables-global-market-report

COVID-19 Drug Associated APIs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report

Dermatology Medical Lasers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: